Cosciens Biopharma Q1 EPS $2.90 Up From $(1.16) YoY, Sales $1.888M Up From $1.387M YoY

Benzinga Newsdesk www.benzinga.com Positive 95.1%

Neg 0% Neu 0% Pos 95.1%

Cosciens Biopharma (OTC:CSCIF) reported quarterly earnings of $2.90 per share. This is a 350 percent increase over losses of $(1.16) per share from the same period last year. The company reported $1.888 million in sales this quarter. This is a 36.12 percent increase over sales of $1.387 million the same period last year.